18 funds hold it.Insiders net selling.
Net buying: insiders sold $0 and bought $102K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsLast report
Aug 4, 2026
Period ending
Jun 30, 2026
Earnings per share
$2.55 expected
Revenue
Financial statements: Alpha Vantage
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Jun 30, 2026Reported Aug 4, 2026 | $2.21est. $2.55 | -13.33%miss | $60.1MAlpha Vantage | +1.0%from $59.5M |
| Mar 31, 2026Reported May 27, 2026 | $1.83est. $1.39 | +31.47%beat | $63.7MAlpha Vantage | +2.6%from $62.1M |
| Dec 31, 2025Reported Feb 3, 2026 | $1.76est. $1.47 | +19.73%beat | $65.1MAlpha Vantage | +3.6%from $62.8M |
| Sep 30, 2025Reported Nov 6, 2025 | $2.11est. $1.56 | +35.26%beat | $60.7MAlpha Vantage | +5.0%from $57.8M |
| Jun 30, 2025Reported Aug 5, 2025 | $1.88est. $2.16 | -12.96%miss | $59.5MAlpha Vantage | +2.4%from $58.2M |
| Mar 31, 2025Reported May 28, 2025 | $2.25est. $1.91 | +17.80%beat | $62.1MAlpha Vantage | +5.5%from $58.9M |
| Dec 31, 2024Reported Feb 4, 2025 | $0.79est. $1.51 | -47.68%miss | $62.8MAlpha Vantage | +17.5%from $53.5M |
| Sep 30, 2024Reported Nov 7, 2024 | $2.16est. $1.38 | +56.52%beat | $57.8MAlpha Vantage | +8.8%from $53.2M |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $60.7M | $65.1M | $63.7M | $60.1M |
| Cost of what it sold | $23.4M | $23.3M | $17.1M | $21.1M |
| Gross profit | $37.3M | $41.8M | $46.6M | $39.0M |
| What it spent | ||||
| Research and development | $5.0M | $5.0M | $5.2M | $4.7M |
| Sales and admin | $17.8M | $18.8M | $24.1M | $17.4M |
| Other operating costs | $9.8M | $10.0M | $14.5M | $9.9M |
| Total operating expenses | $32.6M | $33.8M | $43.9M | $32.0M |
| What was left | ||||
| Operating profit | $4.7M | $8.0M | $2.7M | $7.0M |
| Interest on debt | $2.9M | $3.0M | $2.6M | $2.4M |
| Profit before tax | $2.0M | $4.6M | -$1.6M | $4.4M |
| Tax | -$477.0K | $966.0K | $2.5M | $1.5M |
| Net profit | $2.5M | $3.6M | -$4.1M | $2.8M |
| EBITDA | $10.7M | $13.3M | $4.2M | $12.4M |
This stock's price action is mixed.
Trend
Mixed
40 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
20 macro signals shaping MLAB right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results